Journal of Infection and Public Health. 2013; 6 (2): 108-114
in English
| IMEMR
| ID: emr-142707
ABSTRACT
This study aimed to determine the prevalence of extended spectrum of beta lactamases [ESBLs], to compare different phenotypic methods for ESBL confirmation and to evaluate the antibiotic resistance patterns among ESBL-producing urinary Escherichia coli. Urinary E. coli isolates that were resistant to at least one of the three indicator cephalosporins [cefotaxime, cefpodoxime and ceftazidime] were tested for ESBL production using the double disc synergy test [DDST], the inhibitory potentiated disc diffusion [IPDD] test and the quantitative E-strip method. Of the 163 E. coli strains isolated, 80 [49%] were resistant to at least one of the three cephalosporins, and 38 [47.5%] tested positive for ESBLs by the IPDD test and the E-strip test. However, only15 [18.7%] strains tested positive by the DDST. Among the third-generation cephalosporins, cefpodoxime [46.1%] was the best screening indicator, followed by ceftazidime [43%] and cefotaxime [39.9%]. Most of the ESBL producers [97.3%] were resistant to three or more drugs, compared with 51.2% of non-ESBL producers. Compared with the DDST, the IPDD and E-strip tests appear to be preferable methods for detecting ESBLs, with better sensitivity [100%] and specificilty [97.6%] and positive predictive values [97.3%]. ESBL producers showed significantly [p < 0.05] higher resistance to tobramycin, co-amoxyclav and amikacin than did non-ESBL producers
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Phenotype
/
Rural Population
/
Urinary Tract Infections
/
Beta-Lactamases
/
Microbial Sensitivity Tests
/
Cephalosporin Resistance
/
Escherichia coli Infections
/
Anti-Bacterial Agents
Limits:
Humans
Language:
English
Journal:
J. Infection Public Health
Year:
2013
Similar
MEDLINE
...
LILACS
LIS